Watch Ticker

Milestone Pharmaceuticals Inc. Common Shares

Go to Milestone Pharmaceuticals Inc. Common Shares Website

$1.50

0.01 (0.67%)

Live

Previous Close

$1.49

Day Range

$1.46 - $1.5397

Previous Day Range

$1.43 - $1.495

Market Cap

$121.5 million USD

Day Vol.

237454

Previous Day Vol.

581783

Currency

USD

Primary Exchange

Nasdaq

Milestone Pharmaceuticals Inc is a biopharmaceutical company dedicated to developing and commercializing etripamil for the treatment of cardiovascular medicines. Etripamil is a calcium channel blocker developed as a rapid-onset nasal spray to be admi...

Community

0 posts discussing

0

Watchers

0

Visitors

Recent News

Researchandmarkets.Com - Atrial Fibrillation (AF) Pipeline Market Research Report 2025 | Insights on 10+ Companies and 12+ Drugs in the Pipeline Landscape

A comprehensive market research report analyzing the Atrial Fibrillation pipeline, covering over 10 companies and 12+ pipeline drugs, highlighting emerging treatments, clinical trials, and key developments in managing cardiac arrhythmia.

Related tickers: MIST.

Read Full Article

Globe Newswire - Milestone Pharmaceuticals Announces Proposed Public Offering

Milestone Pharmaceuticals has initiated an underwritten public offering of common shares and warrants to raise funds for clinical development and commercial launch of etripamil, a treatment for paroxysmal supraventricular tachycardia (PSVT).

Related tickers: MIST, PIPR, WFC, WFCpA, WFCpC, WFCpD, WFCpL, WFCpY, WFCpZ.

Read Full Article

Trending Tickers

Please sign in to view